Ratings and Reviews 0 Ratings

Total 0 out of 5 stars
ease 0 out of 5 stars
features 0 out of 5 stars
design 0 out of 5 stars
support 0 out of 5 stars

This software has no reviews. Be the first to write a review.

Write a Review

Ratings and Reviews 0 Ratings

Total 0 out of 5 stars
ease 0 out of 5 stars
features 0 out of 5 stars
design 0 out of 5 stars
support 0 out of 5 stars

This software has no reviews. Be the first to write a review.

Write a Review

Alternatives to Consider

  • Google Cloud Speech-to-Text Reviews & Ratings
    4.5 out of 5 stars 443 Ratings
    Company Website for Google Cloud Speech-to-Text
  • Jama Connect Reviews & Ratings
    4.3 out of 5 stars 416 Ratings
    Company Website for Jama Connect
  • optivalue.ai Reviews & Ratings
    5.0 out of 5 stars 4 Ratings
    Company Website for optivalue.ai
  • Epicor Connected Process Control Reviews & Ratings
    4.9 out of 5 stars 4 Ratings
    Company Website for Epicor Connected Process Control
  • Screencapt Reviews & Ratings
    4.8 out of 5 stars 140 Ratings
    Company Website for Screencapt
  • D&B Connect Reviews & Ratings
    4.1 out of 5 stars 189 Ratings
    Company Website for D&B Connect
  • DrayMaster Reviews & Ratings
    5.0 out of 5 stars 1 Rating
    Company Website for DrayMaster
  • TriNet Reviews & Ratings
    4.2 out of 5 stars 1,994 Ratings
    Company Website for TriNet
  • Adobe Acrobat Reviews & Ratings
    4.5 out of 5 stars 8,459 Ratings
    Company Website for Adobe Acrobat
  • BackUp Maker Reviews & Ratings
    5.0 out of 5 stars 20 Ratings
    Company Website for BackUp Maker

What is Gritstone?

At the core of our immunotherapy strategy is our deep understanding of antigens and neoantigens, especially when it comes to pinpointing which variations will be transcribed, translated, processed, and ultimately presented on cell surfaces through Human leukocyte antigen (HLA) molecules, making them identifiable to T cells. We utilize Gritstone EDGETM, an innovative platform that leverages machine learning to facilitate this process. The development of cancer immunotherapies that target tumor-specific neoantigens is particularly challenging due to the multitude of mutations present in tumors, where only a select few translate into true tumor-specific neoantigens. To address this intricate issue, we have engineered EDGE's advanced integrated neural network model, which has been trained on millions of data points sourced from a wide array of tumor and normal tissue samples derived from various patient backgrounds. This comprehensive training significantly boosts our ability to accurately identify neoantigens and enhances the overall effectiveness of our immunotherapy approaches, ultimately aiming to provide more targeted and effective treatments for patients. By continually refining our methods and expanding our databases, we strive to stay at the forefront of cancer immunotherapy advancements.

What is Atomwise?

Our cutting-edge AI platform is transforming the drug discovery landscape, allowing us to create high-quality medications more rapidly than ever before. Backed by a wide array of discovery assets, both independently owned and co-developed with partners, and supported by prestigious investors, we are making considerable advancements in the sector. Atomwise has developed a machine-learning discovery engine that harnesses the power of convolutional neural networks in conjunction with vast chemical libraries to pinpoint new small-molecule drugs. The true potential of AI in revolutionizing drug discovery is rooted in the dedication and expertise of our team. We are committed to developing state-of-the-art AI tools that enhance the discovery of small molecules, targeting some of the most challenging and seemingly impossible objectives while optimizing the overall drug development process. By increasing computational efficiency, we can digitally screen trillions of compounds, significantly improving the likelihood of successful outcomes. Our models have achieved exceptional accuracy, effectively reducing the occurrence of false positives and setting the stage for groundbreaking medical innovations. As we continue to refine our technology, our ultimate goal is to equip researchers with the necessary tools to inspire innovation and deliver impactful results in the realm of drug discovery. This commitment to advancing the field is at the core of our mission.

Media

Media

Integrations Supported

Additional information not provided

Integrations Supported

Additional information not provided

API Availability

API Availability

Pricing Information

Pricing not provided

Pricing Information

Pricing not provided

Supported Platforms

SaaS

Supported Platforms

SaaS

Customer Service / Support

Web-Based Support

Customer Service / Support

Web-Based Support

Training Options

Not specified

Training Options

Documentation Hub
Webinars
On-Site Training

Company Facts

Organization Name

Gritstone bio

Date Founded

2015

Company Location

United States

Company Website

gritstonebio.com/scientific-platform/

Company Facts

Organization Name

Atomwise

Date Founded

2012

Company Location

United States

Company Website

www.atomwise.com

Categories and Features

Drug Discovery

Not specified

Categories and Features

Drug Discovery

Not specified

Healthcare AI

Not specified

Popular Alternatives

MIStar Reviews & Ratings

MIStar

Apollo Medical Imaging Technology

Popular Alternatives

StarDrop Reviews & Ratings

StarDrop

Optibrium
AIDDISON Reviews & Ratings

AIDDISON

Merck KGaA